Literature DB >> 12467313

Infection in penetrating abdominal trauma: risk factors and preventive antibiotics.

Timothy C Fabian1.   

Abstract

Infection remains the greatest risk for victims of penetrating abdominal injury with major infections occurring in 10 to 15 per cent. Attributable mortality is approximately 30 per cent of those who develop major abdominal infections. In addition to this morbidity infection adds approximately $43,000.00 of hospital charges per infected patients. This article addresses two significant areas: risk factors and antibiotic utilization. The most important risk factor is the presence of hollow viscus injury; colonic wounding carries the highest incidence of infection relative to intra-abdominal organs injured. Pancreatic and liver injuries significantly increase infection risk when combined with hollow viscus wounds. The degree of injury as measured by the volume of hemorrhage and the presence of shock as well as the anatomic degree of injury likewise correlates with the incidence of septic morbidity. Antibiotic utilization is addressed by the three issues of antibiotic agents of choice, duration of administration, and optimal dosing. Regimens of choice should include anaerobic coverage. Twenty-four hours of antibiotic administration is satisfactory with currently available agents. Evidence-based medicine analyses from the Eastern Association for the Surgery of Trauma have addressed those two issues. There are few data on optimal dosing. Increased volumes of distribution and rates of excretion have been demonstrated in trauma patients. This would suggest that higher-than-normal doses should be used. Laboratory studies would support such an approach. However, significant clinical research is desirable to address issues of concentration-dependent bacterial killing and time-dependent killing. Those pharmacodynamic considerations are variable among antibiotic classes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467313

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  [Rectal impalement with rupture of the small intestine].

Authors:  F Wahnschaff; M Gerstorfer; J Roder
Journal:  Chirurg       Date:  2011-06       Impact factor: 0.955

Review 2.  [Perianal and rectal impalement injuries].

Authors:  A K Joos; A Herold; P Palma; S Post
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

3.  Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.

Authors:  Sanmarié Schlebusch; David F M Looke
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Surgical strategies for management of the open abdomen.

Authors:  Justin L Regner; Leslie Kobayashi; Raul Coimbra
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

Review 5.  Swordfish bill injury involving abdomen and vertebral column: case report and review.

Authors:  Despoina Georgiadou; George N Zografos; Dennis Vaidakis; Spiridon Avlonitis; Angeliki Katopodi; Emmanouil N Tzirakis; Panagiotis Sioutos; Charalambos Drossos; Penelope Lampropoulou; George Papastratis
Journal:  BMC Surg       Date:  2010-10-22       Impact factor: 2.102

6.  Planned re-laparotomy and the need for optimization of physiology and immunology.

Authors:  L Kobayashi; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-03-27       Impact factor: 3.693

7.  Severe hemoperitoneum after patient self-induced fecal evacuation.

Authors:  S Gianesini; S Lanzara; R Stano; S Santini; A De Troia; S Gennari; G Vasquez
Journal:  Case Rep Med       Date:  2011-08-24

Review 8.  [Blunt and penetrating trauma the abdomen: retrospective analysis of 175 cases and review of literature].

Authors:  Raherinantenaina Fanomezantsoa; Rakotomena Solonirina Davidà; Rajaonarivony Tianarivelo; Rabetsiahiny Lalao Fabienne; Rajaonanahary Toky Mamin'Ny Aina; Rakototiana Felantsoa Auberlin; Hunald Francis Allen; Rakoto Ratsimba Hery Nirina
Journal:  Pan Afr Med J       Date:  2015-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.